Molecular characterization of human factor XSan Antonio - PubMed
. 1989 Oct;74(5):1486-90.
Affiliations
- PMID: 2790181
Free article
Molecular characterization of human factor XSan Antonio
S V Reddy et al. Blood. 1989 Oct.
Free article
Abstract
Enzymatic amplification technique was used to isolate all eight exons and sequences around the splice junctions, putative promoter, and polyadenylation sites of human factor X DNA from a patient with factor X deficiency. Two genetic changes in factor X have been observed in this patient. The patient is most likely a compound heterozygote since there is only 14% activity associated with factor X. A point mutation that resulted in the substitution of cysteine (TGC) for arginine (CGC) at amino acid 366 was found in exon VIII of one allele of the factor X gene. This mutation, which occurs in the catalytic domain, can affect the formation of a disulfide bridge and thus could result in a reduction in factor X activity. Sequencing all the regions revealed a second mutation: a deletion of one nucleotide (TCCT to TCT) in exon VII that would cause a frame shift at amino acid 272 followed by termination. We have also shown that the point mutation in exon VIII creates an ApaL1 restriction site and destroys the HinP1 site. Enzymatic DNA amplification followed by restriction digestion provides a quick, reliable, and sensitive method for carrier detection and antenatal diagnosis in affected kindreds. This is the first characterization of factor X deficiency at the molecular level. We propose to name this mutation Factor XSan Antonio.
Similar articles
-
Molecular genetic analysis of factor X deficiency: gene deletion and germline mosaicism.
Wieland K, Millar DS, Grundy CB, Mibashan RS, Kakkar VV, Cooper DN. Wieland K, et al. Hum Genet. 1991 Jan;86(3):273-8. doi: 10.1007/BF00202408. Hum Genet. 1991. PMID: 1997381
-
Watzke HH, Lechner K, Roberts HR, Reddy SV, Welsch DJ, Friedman P, Mahr G, Jagadeeswaran P, Monroe DM, High KA. Watzke HH, et al. J Biol Chem. 1990 Jul 15;265(20):11982-9. J Biol Chem. 1990. PMID: 1973167
-
Yin J, Wang H, Wang X. Yin J, et al. Zhonghua Xue Ye Xue Za Zhi. 2001 Sep;22(9):481-3. Zhonghua Xue Ye Xue Za Zhi. 2001. PMID: 11758231 Chinese.
-
Mutations that alter RNA splicing of the human HPRT gene: a review of the spectrum.
O'Neill JP, Rogan PK, Cariello N, Nicklas JA. O'Neill JP, et al. Mutat Res. 1998 Nov;411(3):179-214. doi: 10.1016/s1383-5742(98)00013-1. Mutat Res. 1998. PMID: 9804951 Review.
-
Uprichard J, Perry DJ. Uprichard J, et al. Blood Rev. 2002 Jun;16(2):97-110. doi: 10.1054/blre.2002.0191. Blood Rev. 2002. PMID: 12127953 Review.
Cited by
-
Chikasawa Y, Shinozawa K, Amano K, Ogata K, Hagiwara T, Suzuki T, Inaba H, Fukutake K. Chikasawa Y, et al. Int J Hematol. 2014 Oct;100(4):345-52. doi: 10.1007/s12185-014-1643-6. Epub 2014 Jul 27. Int J Hematol. 2014. PMID: 25064371 Clinical Trial.
-
Blood coagulation factor X: molecular biology, inherited disease, and engineered therapeutics.
Camire RM. Camire RM. J Thromb Thrombolysis. 2021 Aug;52(2):383-390. doi: 10.1007/s11239-021-02456-w. Epub 2021 Apr 22. J Thromb Thrombolysis. 2021. PMID: 33886037 Free PMC article. Review.
-
Krawczak M, Cooper DN. Krawczak M, et al. Hum Genet. 1991 Mar;86(5):425-41. doi: 10.1007/BF00194629. Hum Genet. 1991. PMID: 2016084
-
Watzke HH, Wallmark A, Hamaguchi N, Giardina P, Stafford DW, High KA. Watzke HH, et al. J Clin Invest. 1991 Nov;88(5):1685-9. doi: 10.1172/JCI115484. J Clin Invest. 1991. PMID: 1939653 Free PMC article.
-
Molecular genetic analysis of factor X deficiency: gene deletion and germline mosaicism.
Wieland K, Millar DS, Grundy CB, Mibashan RS, Kakkar VV, Cooper DN. Wieland K, et al. Hum Genet. 1991 Jan;86(3):273-8. doi: 10.1007/BF00202408. Hum Genet. 1991. PMID: 1997381
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases